A multidimensional platform of patient-derived tumors identifies drug susceptibilities for clinical lenvatinib resistance.

Sun L, Wan AH, Yan S, Liu R, Li J, Zhou Z, Wu R, Chen D, Bu X, Ou J, Li K, Lu X, Wan G*, Ke Z*.

Wan Lab authors: 万国辉, 严时佳, 刘若年, 孙蕾, 吴瑞瑞, 李佳蕊